Diagnosis and Treatment of Plasmodium vivax Malaria

J Kevin Baird; Neena Valecha; Stephan Duparc; Nicholas J White; Ric N Price

doi:10.4269/ajtmh.16-0171

Diagnosis and Treatment of Plasmodium vivax Malaria

Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):35-51. doi: 10.4269/ajtmh.16-0171. Epub 2016 Oct 5.

Authors

J Kevin Baird^{1

2}, Neena Valecha³, Stephan Duparc⁴, Nicholas J White^{5

1}, Ric N Price^{6

1}

Affiliations

¹ Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
² Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
³ National Institute for Malaria Research, New Delhi, India.
⁴ Medicines for Malaria Venture, Geneva, Switzerland.
⁵ Mahidol Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
⁶ Division of Global and Tropical Health, Menzies School of Health Research-Charles Darwin University, Darwin, Australia.

Abstract

The diagnosis and treatment of Plasmodium vivax malaria differs from that of Plasmodium falciparum malaria in fundamentally important ways. This article reviews the guiding principles, practices, and evidence underpinning the diagnosis and treatment of P. vivax malaria.

MeSH terms

Antimalarials / pharmacology*
Antimalarials / therapeutic use
Drug Resistance
Humans
Malaria, Vivax / diagnosis*
Malaria, Vivax / drug therapy*
Plasmodium vivax / drug effects*

Substances

Antimalarials

Abstract

MeSH terms

Substances

Grants and funding